Sponsored content
Recent clarification in Sweden’s clinical trial legislation
From 1 July 2026, a clarification in the Swedish Medicines Act has further defined the role of legal representatives in clinical trials—specifically their responsibility to safeguard the individual’s personal interests.
While subtle, this update reinforces:
• Ethical oversight
• Patient protection
• Clear accountability in consent processes
These types of regulatory refinements are a key part of maintaining trust in clinical research.
At Aurevia, we help translate evolving regulations into practical approaches for clinical development.
BREAKING